Российский кардиологический журнал, 2017 The review focuses on cardiorenal syndrome developing in patients with chronic heart failure. The specifics of pathogenesis is discussed, as diagnostics and prognosis, with emphasis on the opportunities of modern biomarker strategy.
E. A. Medvedeva +3 more
doaj +1 more source
Serum NT-pro BNP and Other Biochemical Markers in Patients with Cardiorenal Syndrome (CRS) in Thi- Qar province- Iraq [PDF]
Journal of Bioscience and Applied Research"Any chronic or acute problem in the kidneys or heart which can lead to a chronic or acute problem of the other" is known as "cardiorenal syndrome" (CRS).
Hadeel Faraj
doaj +1 more source
Preliminary approach to cardiorenal syndrome in dogs affected by chronic mitral valve disease [PDF]
, 2015 In human medicine, primary disorders of the heart often result in secondary dysfunction or injury to the kidneys. The coexistence of the two problems in the same patient is referred as cardiorenal syndrome (CRS).
Martinelli, Elisa
core
A comparison of the effects of oral vs. intravenous hydration on subclinical acute kidney injury: a protocol of a randomised controlled trial [PDF]
, 2017 Background: Optimal treatment for established renal failure is living donor kidney transplantation. However this pathway exposes healthy individuals to significant reduction in nephron mass via major surgical procedure.
Aitken, Emma +3 more
core +1 more source
A phenomap of TTR amyloidosis to aid diagnostic screening
ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos +4 more
wiley +1 more source
SA Heart Journal, 2017 The progress made in the medical and device therapy of chronic heart failure (CHF) due to left ventricular systolic dysfunction has heralded new problems.
Eric Klug
doaj +1 more source
British Journal of Pharmacology, EarlyView.Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley +1 more source
Clinical and instrumental features of cardiorenal syndrome in cats with hypertrophic cardiomyopathy
RUDN Journal of Agronomy and Animal IndustriesThis research presents novel insights into the temporal dynamics of clinical and instrumental parameters pertaining to the emergence of cardiorenal syndrome in feline patients afflicted with hypertrophic cardiomyopathy.
Varvara M. Byakhova +3 more
doaj +1 more source
Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?
Life, 2023 The pathologic triangle formed by chronic heart failure (HF), chronic kidney disease (CKD), and anemia carries high morbidity and mortality rates and decreases quality of life.
Oana Nicoleta Buliga-Finis +6 more
doaj +1 more source
Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging [PDF]
, 2012 Background Atherosclerotic renal artery stenosis (ARAS) is common in cardiovascular diseases and associated with hypertension, renal dysfunction and/or heart failure.
AT Hirsch +45 more
core +3 more sources